Motor Neuron Disease News and Research

RSS
Innovative ALS study receives $22 million grant for experimental drug

Innovative ALS study receives $22 million grant for experimental drug

Scientists develop selective therapy for tau tangles

Scientists develop selective therapy for tau tangles

Genetics of Alzheimer's disease and dementia in African populations presented at Nairobi conference

Genetics of Alzheimer's disease and dementia in African populations presented at Nairobi conference

New target identified for potential ALS therapy

New target identified for potential ALS therapy

Proteomic signatures enhance risk prediction for both common and rare diseases

Proteomic signatures enhance risk prediction for both common and rare diseases

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice

Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice

New drug targets key mechanism in ALS, protects motor neurons

New drug targets key mechanism in ALS, protects motor neurons

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

Scientists uncover key protein aggregation in frontotemporal dementia

Scientists uncover key protein aggregation in frontotemporal dementia

Reversing biological age could increase longevity and lower dementia and stroke risk

Reversing biological age could increase longevity and lower dementia and stroke risk

Axon Biology & The Future of Drug Discovery: A Deep Dive with Dr Federico Dajas-Bailador

Axon Biology & The Future of Drug Discovery: A Deep Dive with Dr Federico Dajas-Bailador

Ongoing gene therapy trials have driven increased use of ALS genetic testing, finds study

Ongoing gene therapy trials have driven increased use of ALS genetic testing, finds study

Ohio State University Wexner Medical Center administers first targeted gene therapy for ALS

Ohio State University Wexner Medical Center administers first targeted gene therapy for ALS

Monoclonal antibody shows promise in slowing progression of ALS

Monoclonal antibody shows promise in slowing progression of ALS

Hundreds of proteins and mRNA molecules mislocated in ALS nerve cells

Hundreds of proteins and mRNA molecules mislocated in ALS nerve cells

Older age and certain health conditions increase risk of COVID-19 death in boosted individuals

Older age and certain health conditions increase risk of COVID-19 death in boosted individuals

Parkinson's disease drug ropinirole is safe and tolerable for ALS patients, early clinical trial shows

Parkinson's disease drug ropinirole is safe and tolerable for ALS patients, early clinical trial shows

Same genetic defects shared by some patients with motor neuron disease and frontotemporal dementia

Same genetic defects shared by some patients with motor neuron disease and frontotemporal dementia

UQ research could lead to viable treatments for motor neuron disease

UQ research could lead to viable treatments for motor neuron disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.